English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52836998    線上人數 :  792
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lin y t"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 716-725 / 1310 (共131頁)
<< < 67 68 69 70 71 72 73 74 75 76 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-09-07T06:32:38Z Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer Tzu-Tang Wei;Lin Y.-T.;Tang S.-P.;Luo C.-K.;Tsai C.-T.;Shun C.-T.;Chen C.-C.; TZU-TANG WEI; Lin Y.-T.; Tang S.-P.; Luo C.-K.; Tsai C.-T.; Shun C.-T.; Chen C.-C.
臺大學術典藏 2020-08-18T07:28:24Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Yang J.C.-H.; YU-FEN WANG; Lin Y.-T.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:28Z Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI Chen C.-C.; Fang J.-M.; JIN-YUAN SHIH; Lin Y.-C.; Tseng R.-Y.; Chiu A.-C.; Yeh Y.-H.; Liu C.; Lin Y.-T.; Lin Y.-C.; Chen L.-Y.; Weng C.-H.
臺大學術典藏 2020-08-13T06:33:27Z Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas Gow C.-H.; Hsieh M.-S.; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:27Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Yang J.C.-H.; Yu C.-J.; JIN-YUAN SHIH; Lin Z.-Z.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.
臺大學術典藏 2020-08-13T06:33:26Z The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer Lin Y.-T.;Liu Y.-N.;Jin-Yuan Shih; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:23Z MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process Wang H.-Y.; Liu Y.-N.; Wu S.-G.; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; JIN-YUAN SHIH; Wang H.-Y.;Liu Y.-N.;Wu S.-G.;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Jin-Yuan Shih
臺大學術典藏 2020-08-13T06:33:22Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer JIN-YUAN SHIH; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; Lin Y.-T.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Jin-Yuan Shih
臺大學術典藏 2020-08-13T05:24:02Z Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis 11 Medical and Health Sciences 1103 Clinical Sciences Chung C.-L.; Chen Y.-F.; Lin Y.-T.; JANN-YUAN WANG; Kuo S.-W.; Chen J.-S.
臺大學術典藏 2020-08-12T08:25:24Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; SHANG-GIN WU; Shih J.-Y.; Yang P.-C.

顯示項目 716-725 / 1310 (共131頁)
<< < 67 68 69 70 71 72 73 74 75 76 > >>
每頁顯示[10|25|50]項目